nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—S100B—epilepsy syndrome	0.337	1	CbGaD
Olopatadine—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.0429	0.136	CrCrCtD
Olopatadine—Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.0396	0.125	CrCrCtD
Olopatadine—Doxepin—Oxcarbazepine—epilepsy syndrome	0.0388	0.123	CrCrCtD
Olopatadine—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.0326	0.103	CrCrCtD
Olopatadine—Imipramine—Carbamazepine—epilepsy syndrome	0.0295	0.0934	CrCrCtD
Olopatadine—Clomipramine—Clobazam—epilepsy syndrome	0.0278	0.088	CrCrCtD
Olopatadine—Chlorprothixene—Midazolam—epilepsy syndrome	0.0272	0.0861	CrCrCtD
Olopatadine—Imipramine—Oxcarbazepine—epilepsy syndrome	0.0272	0.0861	CrCrCtD
Olopatadine—Clomipramine—Diazepam—epilepsy syndrome	0.0258	0.0818	CrCrCtD
Olopatadine—Chlorprothixene—Diazepam—epilepsy syndrome	0.0242	0.0767	CrCrCtD
Olopatadine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0126	0.0879	CbGbCtD
Olopatadine—CYP3A4—Trimethadione—epilepsy syndrome	0.0117	0.0817	CbGbCtD
Olopatadine—CYP3A4—Felbamate—epilepsy syndrome	0.0117	0.0817	CbGbCtD
Olopatadine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.011	0.0768	CbGbCtD
Olopatadine—CYP3A4—Clonazepam—epilepsy syndrome	0.00995	0.0695	CbGbCtD
Olopatadine—CYP3A4—Clobazam—epilepsy syndrome	0.00954	0.0666	CbGbCtD
Olopatadine—CYP3A4—Rufinamide—epilepsy syndrome	0.00812	0.0566	CbGbCtD
Olopatadine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00791	0.0552	CbGbCtD
Olopatadine—CYP3A4—Primidone—epilepsy syndrome	0.00738	0.0515	CbGbCtD
Olopatadine—CYP3A4—Phenytoin—epilepsy syndrome	0.00709	0.0495	CbGbCtD
Olopatadine—CYP3A4—Propofol—epilepsy syndrome	0.00662	0.0462	CbGbCtD
Olopatadine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00632	0.0441	CbGbCtD
Olopatadine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00632	0.0441	CbGbCtD
Olopatadine—CYP3A4—Midazolam—epilepsy syndrome	0.00623	0.0435	CbGbCtD
Olopatadine—CYP3A4—Diazepam—epilepsy syndrome	0.00599	0.0418	CbGbCtD
Olopatadine—CYP3A4—Zonisamide—epilepsy syndrome	0.00585	0.0408	CbGbCtD
Olopatadine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00472	0.033	CbGbCtD
Olopatadine—CYP3A4—Topiramate—epilepsy syndrome	0.00426	0.0297	CbGbCtD
Olopatadine—S100A1—ganglion—epilepsy syndrome	0.00391	0.102	CbGeAlD
Olopatadine—S100B—ganglion—epilepsy syndrome	0.00338	0.0877	CbGeAlD
Olopatadine—S100B—hindbrain—epilepsy syndrome	0.00256	0.0665	CbGeAlD
Olopatadine—S100A1—forebrain—epilepsy syndrome	0.00164	0.0426	CbGeAlD
Olopatadine—S100A1—telencephalon—epilepsy syndrome	0.00151	0.0392	CbGeAlD
Olopatadine—S100B—brainstem—epilepsy syndrome	0.00147	0.0381	CbGeAlD
Olopatadine—S100B—forebrain—epilepsy syndrome	0.00142	0.0368	CbGeAlD
Olopatadine—S100B—telencephalon—epilepsy syndrome	0.0013	0.0338	CbGeAlD
Olopatadine—S100A1—medulla oblongata—epilepsy syndrome	0.00119	0.0308	CbGeAlD
Olopatadine—S100A13—Bortezomib—Lacosamide—epilepsy syndrome	0.00114	1	CbGdCrCtD
Olopatadine—S100A1—midbrain—epilepsy syndrome	0.00108	0.0281	CbGeAlD
Olopatadine—S100A1—spinal cord—epilepsy syndrome	0.00106	0.0275	CbGeAlD
Olopatadine—S100A2—head—epilepsy syndrome	0.00102	0.0265	CbGeAlD
Olopatadine—S100A1—head—epilepsy syndrome	0.000939	0.0244	CbGeAlD
Olopatadine—S100B—midbrain—epilepsy syndrome	0.000936	0.0243	CbGeAlD
Olopatadine—S100B—spinal cord—epilepsy syndrome	0.000913	0.0237	CbGeAlD
Olopatadine—S100A1—nervous system—epilepsy syndrome	0.00089	0.0231	CbGeAlD
Olopatadine—S100A1—central nervous system—epilepsy syndrome	0.000857	0.0223	CbGeAlD
Olopatadine—S100A1—cerebellum—epilepsy syndrome	0.000838	0.0218	CbGeAlD
Olopatadine—S100A13—head—epilepsy syndrome	0.000833	0.0216	CbGeAlD
Olopatadine—S100A12—head—epilepsy syndrome	0.000822	0.0214	CbGeAlD
Olopatadine—S100B—head—epilepsy syndrome	0.000811	0.0211	CbGeAlD
Olopatadine—S100A13—nervous system—epilepsy syndrome	0.00079	0.0205	CbGeAlD
Olopatadine—S100B—nervous system—epilepsy syndrome	0.000769	0.02	CbGeAlD
Olopatadine—S100A13—central nervous system—epilepsy syndrome	0.000761	0.0198	CbGeAlD
Olopatadine—S100A13—cerebellum—epilepsy syndrome	0.000743	0.0193	CbGeAlD
Olopatadine—S100B—central nervous system—epilepsy syndrome	0.000741	0.0192	CbGeAlD
Olopatadine—S100A2—brain—epilepsy syndrome	0.000739	0.0192	CbGeAlD
Olopatadine—S100B—cerebellum—epilepsy syndrome	0.000724	0.0188	CbGeAlD
Olopatadine—S100A1—brain—epilepsy syndrome	0.000681	0.0177	CbGeAlD
Olopatadine—S100A13—brain—epilepsy syndrome	0.000604	0.0157	CbGeAlD
Olopatadine—S100A12—brain—epilepsy syndrome	0.000596	0.0155	CbGeAlD
Olopatadine—S100B—brain—epilepsy syndrome	0.000588	0.0153	CbGeAlD
Olopatadine—HRH1—forebrain—epilepsy syndrome	0.000291	0.00755	CbGeAlD
Olopatadine—HRH1—telencephalon—epilepsy syndrome	0.000267	0.00694	CbGeAlD
Olopatadine—Imipramine—KCND2—epilepsy syndrome	0.000196	0.0589	CrCbGaD
Olopatadine—Amitriptyline—KCND2—epilepsy syndrome	0.000195	0.0585	CrCbGaD
Olopatadine—Amitriptyline—KCNQ2—epilepsy syndrome	0.000181	0.0544	CrCbGaD
Olopatadine—Amitriptyline—KCNQ3—epilepsy syndrome	0.000181	0.0544	CrCbGaD
Olopatadine—HRH1—head—epilepsy syndrome	0.000166	0.00432	CbGeAlD
Olopatadine—HRH1—nervous system—epilepsy syndrome	0.000158	0.0041	CbGeAlD
Olopatadine—Amitriptyline—NTRK2—epilepsy syndrome	0.000154	0.0463	CrCbGaD
Olopatadine—HRH1—central nervous system—epilepsy syndrome	0.000152	0.00395	CbGeAlD
Olopatadine—Dimetindene—CHRM2—epilepsy syndrome	0.000126	0.0381	CrCbGaD
Olopatadine—CYP3A4—nervous system—epilepsy syndrome	0.000122	0.00317	CbGeAlD
Olopatadine—HRH1—brain—epilepsy syndrome	0.000121	0.00313	CbGeAlD
Olopatadine—CYP3A4—central nervous system—epilepsy syndrome	0.000117	0.00305	CbGeAlD
Olopatadine—Chlorprothixene—CHRM3—epilepsy syndrome	7.85e-05	0.0236	CrCbGaD
Olopatadine—Nortriptyline—CHRM3—epilepsy syndrome	7.71e-05	0.0232	CrCbGaD
Olopatadine—Chlorprothixene—CHRM1—epilepsy syndrome	7.33e-05	0.022	CrCbGaD
Olopatadine—Nortriptyline—CHRM1—epilepsy syndrome	7.19e-05	0.0216	CrCbGaD
Olopatadine—Doxepin—CHRM3—epilepsy syndrome	6.92e-05	0.0208	CrCbGaD
Olopatadine—Vomiting—Propofol—epilepsy syndrome	6.52e-05	0.000618	CcSEcCtD
Olopatadine—Muscle spasms—Pregabalin—epilepsy syndrome	6.5e-05	0.000616	CcSEcCtD
Olopatadine—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	6.5e-05	0.000616	CcSEcCtD
Olopatadine—Pruritus—Diazepam—epilepsy syndrome	6.5e-05	0.000616	CcSEcCtD
Olopatadine—Conjunctivitis—Topiramate—epilepsy syndrome	6.49e-05	0.000615	CcSEcCtD
Olopatadine—Urinary tract infection—Topiramate—epilepsy syndrome	6.49e-05	0.000615	CcSEcCtD
Olopatadine—Thiothixene—ADRA2A—epilepsy syndrome	6.49e-05	0.0195	CrCbGaD
Olopatadine—Rash—Propofol—epilepsy syndrome	6.47e-05	0.000613	CcSEcCtD
Olopatadine—Dermatitis—Propofol—epilepsy syndrome	6.46e-05	0.000612	CcSEcCtD
Olopatadine—Doxepin—CHRM1—epilepsy syndrome	6.45e-05	0.0194	CrCbGaD
Olopatadine—Immune system disorder—Gabapentin—epilepsy syndrome	6.43e-05	0.00061	CcSEcCtD
Olopatadine—Headache—Propofol—epilepsy syndrome	6.43e-05	0.000609	CcSEcCtD
Olopatadine—Mediastinal disorder—Gabapentin—epilepsy syndrome	6.42e-05	0.000608	CcSEcCtD
Olopatadine—Hypersensitivity—Zonisamide—epilepsy syndrome	6.41e-05	0.000607	CcSEcCtD
Olopatadine—Vomiting—Midazolam—epilepsy syndrome	6.38e-05	0.000605	CcSEcCtD
Olopatadine—Diarrhoea—Vigabatrin—epilepsy syndrome	6.38e-05	0.000605	CcSEcCtD
Olopatadine—Asthenia—Felbamate—epilepsy syndrome	6.38e-05	0.000604	CcSEcCtD
Olopatadine—Vision blurred—Pregabalin—epilepsy syndrome	6.37e-05	0.000604	CcSEcCtD
Olopatadine—Feeling abnormal—Lamotrigine—epilepsy syndrome	6.33e-05	0.0006	CcSEcCtD
Olopatadine—Rash—Midazolam—epilepsy syndrome	6.33e-05	0.0006	CcSEcCtD
Olopatadine—Dizziness—Fosphenytoin—epilepsy syndrome	6.33e-05	0.0006	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	6.32e-05	0.000599	CcSEcCtD
Olopatadine—Dermatitis—Midazolam—epilepsy syndrome	6.32e-05	0.000599	CcSEcCtD
Olopatadine—Vomiting—Levetiracetam—epilepsy syndrome	6.3e-05	0.000597	CcSEcCtD
Olopatadine—Epistaxis—Topiramate—epilepsy syndrome	6.3e-05	0.000597	CcSEcCtD
Olopatadine—Amitriptyline—OPRD1—epilepsy syndrome	6.29e-05	0.0189	CrCbGaD
Olopatadine—Discomfort—Valproic Acid—epilepsy syndrome	6.29e-05	0.000596	CcSEcCtD
Olopatadine—Headache—Midazolam—epilepsy syndrome	6.29e-05	0.000596	CcSEcCtD
Olopatadine—Pruritus—Felbamate—epilepsy syndrome	6.29e-05	0.000596	CcSEcCtD
Olopatadine—Abdominal pain—Carbamazepine—epilepsy syndrome	6.28e-05	0.000595	CcSEcCtD
Olopatadine—Body temperature increased—Carbamazepine—epilepsy syndrome	6.28e-05	0.000595	CcSEcCtD
Olopatadine—Diarrhoea—Diazepam—epilepsy syndrome	6.28e-05	0.000595	CcSEcCtD
Olopatadine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	6.28e-05	0.000595	CcSEcCtD
Olopatadine—Ill-defined disorder—Pregabalin—epilepsy syndrome	6.27e-05	0.000595	CcSEcCtD
Olopatadine—Sinusitis—Topiramate—epilepsy syndrome	6.26e-05	0.000593	CcSEcCtD
Olopatadine—Rash—Levetiracetam—epilepsy syndrome	6.25e-05	0.000592	CcSEcCtD
Olopatadine—Dermatitis—Levetiracetam—epilepsy syndrome	6.24e-05	0.000592	CcSEcCtD
Olopatadine—Asthenia—Zonisamide—epilepsy syndrome	6.24e-05	0.000591	CcSEcCtD
Olopatadine—Dry mouth—Valproic Acid—epilepsy syndrome	6.23e-05	0.00059	CcSEcCtD
Olopatadine—Headache—Levetiracetam—epilepsy syndrome	6.21e-05	0.000589	CcSEcCtD
Olopatadine—Erythema—Gabapentin—epilepsy syndrome	6.2e-05	0.000588	CcSEcCtD
Olopatadine—Hypersensitivity—Clonazepam—epilepsy syndrome	6.18e-05	0.000585	CcSEcCtD
Olopatadine—Dizziness—Vigabatrin—epilepsy syndrome	6.17e-05	0.000584	CcSEcCtD
Olopatadine—Pruritus—Zonisamide—epilepsy syndrome	6.15e-05	0.000583	CcSEcCtD
Olopatadine—Hypersensitivity—Phenytoin—epilepsy syndrome	6.13e-05	0.000581	CcSEcCtD
Olopatadine—Oedema—Valproic Acid—epilepsy syndrome	6.1e-05	0.000578	CcSEcCtD
Olopatadine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	6.1e-05	0.000578	CcSEcCtD
Olopatadine—Malaise—Pregabalin—epilepsy syndrome	6.1e-05	0.000578	CcSEcCtD
Olopatadine—Nausea—Propofol—epilepsy syndrome	6.09e-05	0.000578	CcSEcCtD
Olopatadine—Vomiting—Fosphenytoin—epilepsy syndrome	6.08e-05	0.000576	CcSEcCtD
Olopatadine—Diarrhoea—Felbamate—epilepsy syndrome	6.08e-05	0.000576	CcSEcCtD
Olopatadine—Abdominal pain—Lamotrigine—epilepsy syndrome	6.07e-05	0.000575	CcSEcCtD
Olopatadine—Body temperature increased—Lamotrigine—epilepsy syndrome	6.07e-05	0.000575	CcSEcCtD
Olopatadine—Dysgeusia—Gabapentin—epilepsy syndrome	6.07e-05	0.000575	CcSEcCtD
Olopatadine—Dizziness—Diazepam—epilepsy syndrome	6.07e-05	0.000575	CcSEcCtD
Olopatadine—Infection—Valproic Acid—epilepsy syndrome	6.06e-05	0.000575	CcSEcCtD
Olopatadine—Rash—Fosphenytoin—epilepsy syndrome	6.03e-05	0.000572	CcSEcCtD
Olopatadine—Dermatitis—Fosphenytoin—epilepsy syndrome	6.03e-05	0.000571	CcSEcCtD
Olopatadine—Asthenia—Clonazepam—epilepsy syndrome	6.01e-05	0.00057	CcSEcCtD
Olopatadine—Rhinitis—Topiramate—epilepsy syndrome	6.01e-05	0.000569	CcSEcCtD
Olopatadine—Back pain—Gabapentin—epilepsy syndrome	6e-05	0.000568	CcSEcCtD
Olopatadine—Headache—Fosphenytoin—epilepsy syndrome	5.99e-05	0.000568	CcSEcCtD
Olopatadine—Nervous system disorder—Valproic Acid—epilepsy syndrome	5.99e-05	0.000567	CcSEcCtD
Olopatadine—Chlorprothixene—CHRM2—epilepsy syndrome	5.98e-05	0.018	CrCbGaD
Olopatadine—Asthenia—Phenytoin—epilepsy syndrome	5.97e-05	0.000566	CcSEcCtD
Olopatadine—Nausea—Midazolam—epilepsy syndrome	5.96e-05	0.000565	CcSEcCtD
Olopatadine—Hypoaesthesia—Topiramate—epilepsy syndrome	5.96e-05	0.000565	CcSEcCtD
Olopatadine—Muscle spasms—Gabapentin—epilepsy syndrome	5.96e-05	0.000565	CcSEcCtD
Olopatadine—Diarrhoea—Zonisamide—epilepsy syndrome	5.95e-05	0.000564	CcSEcCtD
Olopatadine—Pharyngitis—Topiramate—epilepsy syndrome	5.95e-05	0.000564	CcSEcCtD
Olopatadine—Asthenia—Oxcarbazepine—epilepsy syndrome	5.94e-05	0.000563	CcSEcCtD
Olopatadine—Pruritus—Clonazepam—epilepsy syndrome	5.93e-05	0.000562	CcSEcCtD
Olopatadine—Vomiting—Vigabatrin—epilepsy syndrome	5.93e-05	0.000562	CcSEcCtD
Olopatadine—Skin disorder—Valproic Acid—epilepsy syndrome	5.93e-05	0.000562	CcSEcCtD
Olopatadine—Cough—Pregabalin—epilepsy syndrome	5.9e-05	0.000559	CcSEcCtD
Olopatadine—Pruritus—Phenytoin—epilepsy syndrome	5.89e-05	0.000558	CcSEcCtD
Olopatadine—Nausea—Levetiracetam—epilepsy syndrome	5.89e-05	0.000558	CcSEcCtD
Olopatadine—Rash—Vigabatrin—epilepsy syndrome	5.88e-05	0.000557	CcSEcCtD
Olopatadine—Dizziness—Felbamate—epilepsy syndrome	5.88e-05	0.000557	CcSEcCtD
Olopatadine—Dermatitis—Vigabatrin—epilepsy syndrome	5.87e-05	0.000557	CcSEcCtD
Olopatadine—Nortriptyline—CHRM2—epilepsy syndrome	5.87e-05	0.0177	CrCbGaD
Olopatadine—Pruritus—Oxcarbazepine—epilepsy syndrome	5.86e-05	0.000555	CcSEcCtD
Olopatadine—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.86e-05	0.000555	CcSEcCtD
Olopatadine—Vision blurred—Gabapentin—epilepsy syndrome	5.84e-05	0.000554	CcSEcCtD
Olopatadine—Headache—Vigabatrin—epilepsy syndrome	5.84e-05	0.000554	CcSEcCtD
Olopatadine—Vomiting—Diazepam—epilepsy syndrome	5.84e-05	0.000553	CcSEcCtD
Olopatadine—Rash—Diazepam—epilepsy syndrome	5.79e-05	0.000549	CcSEcCtD
Olopatadine—Dermatitis—Diazepam—epilepsy syndrome	5.78e-05	0.000548	CcSEcCtD
Olopatadine—Visual impairment—Topiramate—epilepsy syndrome	5.77e-05	0.000547	CcSEcCtD
Olopatadine—Ill-defined disorder—Gabapentin—epilepsy syndrome	5.75e-05	0.000545	CcSEcCtD
Olopatadine—Dizziness—Zonisamide—epilepsy syndrome	5.75e-05	0.000545	CcSEcCtD
Olopatadine—Headache—Diazepam—epilepsy syndrome	5.75e-05	0.000545	CcSEcCtD
Olopatadine—Diarrhoea—Clonazepam—epilepsy syndrome	5.74e-05	0.000544	CcSEcCtD
Olopatadine—Cyclobenzaprine—HTR2A—epilepsy syndrome	5.72e-05	0.0172	CrCbGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.72e-05	0.000542	CcSEcCtD
Olopatadine—Asthenia—Carbamazepine—epilepsy syndrome	5.7e-05	0.00054	CcSEcCtD
Olopatadine—Diarrhoea—Phenytoin—epilepsy syndrome	5.7e-05	0.00054	CcSEcCtD
Olopatadine—Discomfort—Pregabalin—epilepsy syndrome	5.69e-05	0.000539	CcSEcCtD
Olopatadine—Nausea—Fosphenytoin—epilepsy syndrome	5.68e-05	0.000539	CcSEcCtD
Olopatadine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.67e-05	0.000537	CcSEcCtD
Olopatadine—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.66e-05	0.000536	CcSEcCtD
Olopatadine—Vomiting—Felbamate—epilepsy syndrome	5.65e-05	0.000535	CcSEcCtD
Olopatadine—Dry mouth—Pregabalin—epilepsy syndrome	5.63e-05	0.000534	CcSEcCtD
Olopatadine—Pruritus—Carbamazepine—epilepsy syndrome	5.62e-05	0.000533	CcSEcCtD
Olopatadine—Rash—Felbamate—epilepsy syndrome	5.6e-05	0.000531	CcSEcCtD
Olopatadine—Eye disorder—Topiramate—epilepsy syndrome	5.6e-05	0.000531	CcSEcCtD
Olopatadine—Dermatitis—Felbamate—epilepsy syndrome	5.6e-05	0.00053	CcSEcCtD
Olopatadine—Malaise—Gabapentin—epilepsy syndrome	5.59e-05	0.00053	CcSEcCtD
Olopatadine—Headache—Felbamate—epilepsy syndrome	5.57e-05	0.000528	CcSEcCtD
Olopatadine—Dizziness—Clonazepam—epilepsy syndrome	5.54e-05	0.000525	CcSEcCtD
Olopatadine—Nausea—Vigabatrin—epilepsy syndrome	5.54e-05	0.000525	CcSEcCtD
Olopatadine—Vomiting—Zonisamide—epilepsy syndrome	5.53e-05	0.000524	CcSEcCtD
Olopatadine—Oedema—Pregabalin—epilepsy syndrome	5.52e-05	0.000523	CcSEcCtD
Olopatadine—Asthenia—Lamotrigine—epilepsy syndrome	5.51e-05	0.000522	CcSEcCtD
Olopatadine—Dizziness—Phenytoin—epilepsy syndrome	5.51e-05	0.000522	CcSEcCtD
Olopatadine—Rash—Zonisamide—epilepsy syndrome	5.48e-05	0.00052	CcSEcCtD
Olopatadine—Infection—Pregabalin—epilepsy syndrome	5.48e-05	0.00052	CcSEcCtD
Olopatadine—Dermatitis—Zonisamide—epilepsy syndrome	5.48e-05	0.000519	CcSEcCtD
Olopatadine—Dizziness—Oxcarbazepine—epilepsy syndrome	5.48e-05	0.000519	CcSEcCtD
Olopatadine—Nausea—Diazepam—epilepsy syndrome	5.45e-05	0.000517	CcSEcCtD
Olopatadine—Headache—Zonisamide—epilepsy syndrome	5.45e-05	0.000516	CcSEcCtD
Olopatadine—Dyspnoea—Valproic Acid—epilepsy syndrome	5.44e-05	0.000516	CcSEcCtD
Olopatadine—Diarrhoea—Carbamazepine—epilepsy syndrome	5.44e-05	0.000515	CcSEcCtD
Olopatadine—Pruritus—Lamotrigine—epilepsy syndrome	5.43e-05	0.000515	CcSEcCtD
Olopatadine—Somnolence—Valproic Acid—epilepsy syndrome	5.43e-05	0.000514	CcSEcCtD
Olopatadine—Immune system disorder—Topiramate—epilepsy syndrome	5.41e-05	0.000513	CcSEcCtD
Olopatadine—Nervous system disorder—Pregabalin—epilepsy syndrome	5.41e-05	0.000513	CcSEcCtD
Olopatadine—Cough—Gabapentin—epilepsy syndrome	5.41e-05	0.000513	CcSEcCtD
Olopatadine—Mediastinal disorder—Topiramate—epilepsy syndrome	5.4e-05	0.000512	CcSEcCtD
Olopatadine—Imipramine—CHRM3—epilepsy syndrome	5.38e-05	0.0162	CrCbGaD
Olopatadine—Skin disorder—Pregabalin—epilepsy syndrome	5.36e-05	0.000508	CcSEcCtD
Olopatadine—Amitriptyline—CHRM3—epilepsy syndrome	5.35e-05	0.0161	CrCbGaD
Olopatadine—Vomiting—Clonazepam—epilepsy syndrome	5.33e-05	0.000505	CcSEcCtD
Olopatadine—Vomiting—Phenytoin—epilepsy syndrome	5.29e-05	0.000502	CcSEcCtD
Olopatadine—Rash—Clonazepam—epilepsy syndrome	5.29e-05	0.000501	CcSEcCtD
Olopatadine—Dermatitis—Clonazepam—epilepsy syndrome	5.28e-05	0.0005	CcSEcCtD
Olopatadine—Nausea—Felbamate—epilepsy syndrome	5.28e-05	0.0005	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.27e-05	0.000499	CcSEcCtD
Olopatadine—Doxepin—CHRM2—epilepsy syndrome	5.27e-05	0.0159	CrCbGaD
Olopatadine—Vomiting—Oxcarbazepine—epilepsy syndrome	5.27e-05	0.000499	CcSEcCtD
Olopatadine—Fatigue—Valproic Acid—epilepsy syndrome	5.26e-05	0.000499	CcSEcCtD
Olopatadine—Dizziness—Carbamazepine—epilepsy syndrome	5.26e-05	0.000498	CcSEcCtD
Olopatadine—Diarrhoea—Lamotrigine—epilepsy syndrome	5.26e-05	0.000498	CcSEcCtD
Olopatadine—Headache—Clonazepam—epilepsy syndrome	5.25e-05	0.000498	CcSEcCtD
Olopatadine—Rash—Phenytoin—epilepsy syndrome	5.25e-05	0.000498	CcSEcCtD
Olopatadine—Dermatitis—Phenytoin—epilepsy syndrome	5.25e-05	0.000497	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.24e-05	0.000497	CcSEcCtD
Olopatadine—Cyclobenzaprine—CYP2D6—epilepsy syndrome	5.23e-05	0.0158	CrCbGaD
Olopatadine—Rash—Oxcarbazepine—epilepsy syndrome	5.22e-05	0.000495	CcSEcCtD
Olopatadine—Pain—Valproic Acid—epilepsy syndrome	5.22e-05	0.000495	CcSEcCtD
Olopatadine—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.22e-05	0.000494	CcSEcCtD
Olopatadine—Headache—Phenytoin—epilepsy syndrome	5.22e-05	0.000494	CcSEcCtD
Olopatadine—Erythema—Topiramate—epilepsy syndrome	5.22e-05	0.000494	CcSEcCtD
Olopatadine—Discomfort—Gabapentin—epilepsy syndrome	5.22e-05	0.000494	CcSEcCtD
Olopatadine—Headache—Oxcarbazepine—epilepsy syndrome	5.19e-05	0.000492	CcSEcCtD
Olopatadine—Nausea—Zonisamide—epilepsy syndrome	5.17e-05	0.00049	CcSEcCtD
Olopatadine—Dry mouth—Gabapentin—epilepsy syndrome	5.16e-05	0.000489	CcSEcCtD
Olopatadine—Clomipramine—ADRA2A—epilepsy syndrome	5.13e-05	0.0154	CrCbGaD
Olopatadine—Dysgeusia—Topiramate—epilepsy syndrome	5.11e-05	0.000484	CcSEcCtD
Olopatadine—Dizziness—Lamotrigine—epilepsy syndrome	5.08e-05	0.000481	CcSEcCtD
Olopatadine—Oedema—Gabapentin—epilepsy syndrome	5.06e-05	0.00048	CcSEcCtD
Olopatadine—Vomiting—Carbamazepine—epilepsy syndrome	5.05e-05	0.000479	CcSEcCtD
Olopatadine—Back pain—Topiramate—epilepsy syndrome	5.05e-05	0.000478	CcSEcCtD
Olopatadine—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.03e-05	0.000477	CcSEcCtD
Olopatadine—Infection—Gabapentin—epilepsy syndrome	5.03e-05	0.000476	CcSEcCtD
Olopatadine—Imipramine—CHRM1—epilepsy syndrome	5.02e-05	0.0151	CrCbGaD
Olopatadine—Muscle spasms—Topiramate—epilepsy syndrome	5.02e-05	0.000475	CcSEcCtD
Olopatadine—Rash—Carbamazepine—epilepsy syndrome	5.01e-05	0.000475	CcSEcCtD
Olopatadine—Dermatitis—Carbamazepine—epilepsy syndrome	5.01e-05	0.000474	CcSEcCtD
Olopatadine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.99e-05	0.000473	CcSEcCtD
Olopatadine—Amitriptyline—CHRM1—epilepsy syndrome	4.99e-05	0.015	CrCbGaD
Olopatadine—Nausea—Clonazepam—epilepsy syndrome	4.98e-05	0.000472	CcSEcCtD
Olopatadine—Headache—Carbamazepine—epilepsy syndrome	4.98e-05	0.000472	CcSEcCtD
Olopatadine—Nervous system disorder—Gabapentin—epilepsy syndrome	4.96e-05	0.00047	CcSEcCtD
Olopatadine—Nausea—Phenytoin—epilepsy syndrome	4.95e-05	0.000469	CcSEcCtD
Olopatadine—Dyspnoea—Pregabalin—epilepsy syndrome	4.92e-05	0.000466	CcSEcCtD
Olopatadine—Nausea—Oxcarbazepine—epilepsy syndrome	4.92e-05	0.000466	CcSEcCtD
Olopatadine—Vision blurred—Topiramate—epilepsy syndrome	4.92e-05	0.000466	CcSEcCtD
Olopatadine—Skin disorder—Gabapentin—epilepsy syndrome	4.92e-05	0.000466	CcSEcCtD
Olopatadine—Somnolence—Pregabalin—epilepsy syndrome	4.91e-05	0.000465	CcSEcCtD
Olopatadine—Vomiting—Lamotrigine—epilepsy syndrome	4.88e-05	0.000463	CcSEcCtD
Olopatadine—Rash—Lamotrigine—epilepsy syndrome	4.84e-05	0.000459	CcSEcCtD
Olopatadine—Ill-defined disorder—Topiramate—epilepsy syndrome	4.84e-05	0.000459	CcSEcCtD
Olopatadine—Dermatitis—Lamotrigine—epilepsy syndrome	4.84e-05	0.000459	CcSEcCtD
Olopatadine—Abdominal pain—Valproic Acid—epilepsy syndrome	4.83e-05	0.000457	CcSEcCtD
Olopatadine—Body temperature increased—Valproic Acid—epilepsy syndrome	4.83e-05	0.000457	CcSEcCtD
Olopatadine—Amitriptyline—OPRM1—epilepsy syndrome	4.81e-05	0.0145	CrCbGaD
Olopatadine—Headache—Lamotrigine—epilepsy syndrome	4.81e-05	0.000456	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.76e-05	0.000451	CcSEcCtD
Olopatadine—Fatigue—Pregabalin—epilepsy syndrome	4.76e-05	0.000451	CcSEcCtD
Olopatadine—Nausea—Carbamazepine—epilepsy syndrome	4.72e-05	0.000447	CcSEcCtD
Olopatadine—Pain—Pregabalin—epilepsy syndrome	4.72e-05	0.000447	CcSEcCtD
Olopatadine—Malaise—Topiramate—epilepsy syndrome	4.7e-05	0.000446	CcSEcCtD
Olopatadine—Nausea—Lamotrigine—epilepsy syndrome	4.56e-05	0.000432	CcSEcCtD
Olopatadine—Cough—Topiramate—epilepsy syndrome	4.55e-05	0.000431	CcSEcCtD
Olopatadine—Feeling abnormal—Pregabalin—epilepsy syndrome	4.55e-05	0.000431	CcSEcCtD
Olopatadine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.51e-05	0.000428	CcSEcCtD
Olopatadine—Dyspnoea—Gabapentin—epilepsy syndrome	4.51e-05	0.000428	CcSEcCtD
Olopatadine—Somnolence—Gabapentin—epilepsy syndrome	4.5e-05	0.000426	CcSEcCtD
Olopatadine—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.5e-05	0.000426	CcSEcCtD
Olopatadine—Doxepin—ADRA2A—epilepsy syndrome	4.5e-05	0.0135	CrCbGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.41e-05	0.000418	CcSEcCtD
Olopatadine—Discomfort—Topiramate—epilepsy syndrome	4.39e-05	0.000416	CcSEcCtD
Olopatadine—Asthenia—Valproic Acid—epilepsy syndrome	4.38e-05	0.000415	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.37e-05	0.000414	CcSEcCtD
Olopatadine—Fatigue—Gabapentin—epilepsy syndrome	4.36e-05	0.000413	CcSEcCtD
Olopatadine—Abdominal pain—Pregabalin—epilepsy syndrome	4.36e-05	0.000413	CcSEcCtD
Olopatadine—Body temperature increased—Pregabalin—epilepsy syndrome	4.36e-05	0.000413	CcSEcCtD
Olopatadine—Dry mouth—Topiramate—epilepsy syndrome	4.34e-05	0.000412	CcSEcCtD
Olopatadine—Pain—Gabapentin—epilepsy syndrome	4.33e-05	0.00041	CcSEcCtD
Olopatadine—Pruritus—Valproic Acid—epilepsy syndrome	4.32e-05	0.000409	CcSEcCtD
Olopatadine—Oedema—Topiramate—epilepsy syndrome	4.26e-05	0.000403	CcSEcCtD
Olopatadine—Infection—Topiramate—epilepsy syndrome	4.23e-05	0.000401	CcSEcCtD
Olopatadine—Diarrhoea—Valproic Acid—epilepsy syndrome	4.18e-05	0.000396	CcSEcCtD
Olopatadine—Nervous system disorder—Topiramate—epilepsy syndrome	4.18e-05	0.000396	CcSEcCtD
Olopatadine—Feeling abnormal—Gabapentin—epilepsy syndrome	4.17e-05	0.000395	CcSEcCtD
Olopatadine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.14e-05	0.000392	CcSEcCtD
Olopatadine—Skin disorder—Topiramate—epilepsy syndrome	4.14e-05	0.000392	CcSEcCtD
Olopatadine—Imipramine—CHRM2—epilepsy syndrome	4.1e-05	0.0123	CrCbGaD
Olopatadine—Imipramine—HTR7—epilepsy syndrome	4.08e-05	0.0123	CrCbGaD
Olopatadine—Amitriptyline—CHRM2—epilepsy syndrome	4.07e-05	0.0123	CrCbGaD
Olopatadine—Hypersensitivity—Pregabalin—epilepsy syndrome	4.07e-05	0.000385	CcSEcCtD
Olopatadine—Amitriptyline—HTR7—epilepsy syndrome	4.05e-05	0.0122	CrCbGaD
Olopatadine—Dizziness—Valproic Acid—epilepsy syndrome	4.04e-05	0.000383	CcSEcCtD
Olopatadine—Abdominal pain—Gabapentin—epilepsy syndrome	4e-05	0.000379	CcSEcCtD
Olopatadine—Body temperature increased—Gabapentin—epilepsy syndrome	4e-05	0.000379	CcSEcCtD
Olopatadine—Asthenia—Pregabalin—epilepsy syndrome	3.96e-05	0.000375	CcSEcCtD
Olopatadine—Acepromazine—HTR2A—epilepsy syndrome	3.96e-05	0.0119	CrCbGaD
Olopatadine—Clomipramine—SLC6A4—epilepsy syndrome	3.91e-05	0.0118	CrCbGaD
Olopatadine—Pruritus—Pregabalin—epilepsy syndrome	3.9e-05	0.00037	CcSEcCtD
Olopatadine—Vomiting—Valproic Acid—epilepsy syndrome	3.88e-05	0.000368	CcSEcCtD
Olopatadine—Rash—Valproic Acid—epilepsy syndrome	3.85e-05	0.000365	CcSEcCtD
Olopatadine—Dermatitis—Valproic Acid—epilepsy syndrome	3.85e-05	0.000364	CcSEcCtD
Olopatadine—Headache—Valproic Acid—epilepsy syndrome	3.82e-05	0.000362	CcSEcCtD
Olopatadine—Nortriptyline—SLC6A4—epilepsy syndrome	3.82e-05	0.0115	CrCbGaD
Olopatadine—Thiothixene—HTR2A—epilepsy syndrome	3.8e-05	0.0114	CrCbGaD
Olopatadine—Dyspnoea—Topiramate—epilepsy syndrome	3.8e-05	0.00036	CcSEcCtD
Olopatadine—Somnolence—Topiramate—epilepsy syndrome	3.78e-05	0.000359	CcSEcCtD
Olopatadine—Diarrhoea—Pregabalin—epilepsy syndrome	3.78e-05	0.000358	CcSEcCtD
Olopatadine—Hypersensitivity—Gabapentin—epilepsy syndrome	3.73e-05	0.000353	CcSEcCtD
Olopatadine—Clomipramine—CYP2C19—epilepsy syndrome	3.71e-05	0.0112	CrCbGaD
Olopatadine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.68e-05	0.000348	CcSEcCtD
Olopatadine—Fatigue—Topiramate—epilepsy syndrome	3.67e-05	0.000348	CcSEcCtD
Olopatadine—Dizziness—Pregabalin—epilepsy syndrome	3.65e-05	0.000346	CcSEcCtD
Olopatadine—Pain—Topiramate—epilepsy syndrome	3.64e-05	0.000345	CcSEcCtD
Olopatadine—Asthenia—Gabapentin—epilepsy syndrome	3.63e-05	0.000344	CcSEcCtD
Olopatadine—Nausea—Valproic Acid—epilepsy syndrome	3.63e-05	0.000344	CcSEcCtD
Olopatadine—Nortriptyline—CYP2C19—epilepsy syndrome	3.62e-05	0.0109	CrCbGaD
Olopatadine—Pruritus—Gabapentin—epilepsy syndrome	3.58e-05	0.000339	CcSEcCtD
Olopatadine—Vomiting—Pregabalin—epilepsy syndrome	3.51e-05	0.000333	CcSEcCtD
Olopatadine—Feeling abnormal—Topiramate—epilepsy syndrome	3.51e-05	0.000332	CcSEcCtD
Olopatadine—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.48e-05	0.00033	CcSEcCtD
Olopatadine—Rash—Pregabalin—epilepsy syndrome	3.48e-05	0.00033	CcSEcCtD
Olopatadine—Thiothixene—CYP2D6—epilepsy syndrome	3.48e-05	0.0105	CrCbGaD
Olopatadine—Amitriptyline—ADRA2A—epilepsy syndrome	3.48e-05	0.0105	CrCbGaD
Olopatadine—Dermatitis—Pregabalin—epilepsy syndrome	3.48e-05	0.000329	CcSEcCtD
Olopatadine—Diarrhoea—Gabapentin—epilepsy syndrome	3.46e-05	0.000328	CcSEcCtD
Olopatadine—Headache—Pregabalin—epilepsy syndrome	3.46e-05	0.000328	CcSEcCtD
Olopatadine—Doxepin—SLC6A4—epilepsy syndrome	3.43e-05	0.0103	CrCbGaD
Olopatadine—Abdominal pain—Topiramate—epilepsy syndrome	3.37e-05	0.000319	CcSEcCtD
Olopatadine—Body temperature increased—Topiramate—epilepsy syndrome	3.37e-05	0.000319	CcSEcCtD
Olopatadine—Dizziness—Gabapentin—epilepsy syndrome	3.35e-05	0.000317	CcSEcCtD
Olopatadine—Nausea—Pregabalin—epilepsy syndrome	3.28e-05	0.000311	CcSEcCtD
Olopatadine—Doxepin—CYP2C19—epilepsy syndrome	3.25e-05	0.00979	CrCbGaD
Olopatadine—Vomiting—Gabapentin—epilepsy syndrome	3.22e-05	0.000305	CcSEcCtD
Olopatadine—Rash—Gabapentin—epilepsy syndrome	3.19e-05	0.000302	CcSEcCtD
Olopatadine—Dermatitis—Gabapentin—epilepsy syndrome	3.19e-05	0.000302	CcSEcCtD
Olopatadine—Headache—Gabapentin—epilepsy syndrome	3.17e-05	0.0003	CcSEcCtD
Olopatadine—Hypersensitivity—Topiramate—epilepsy syndrome	3.14e-05	0.000297	CcSEcCtD
Olopatadine—Asthenia—Topiramate—epilepsy syndrome	3.05e-05	0.000289	CcSEcCtD
Olopatadine—Pruritus—Topiramate—epilepsy syndrome	3.01e-05	0.000285	CcSEcCtD
Olopatadine—Clomipramine—HTR2A—epilepsy syndrome	3.01e-05	0.00905	CrCbGaD
Olopatadine—Nausea—Gabapentin—epilepsy syndrome	3.01e-05	0.000285	CcSEcCtD
Olopatadine—Chlorprothixene—HTR2A—epilepsy syndrome	2.99e-05	0.00901	CrCbGaD
Olopatadine—Nortriptyline—HTR2A—epilepsy syndrome	2.94e-05	0.00884	CrCbGaD
Olopatadine—Diarrhoea—Topiramate—epilepsy syndrome	2.91e-05	0.000276	CcSEcCtD
Olopatadine—Dizziness—Topiramate—epilepsy syndrome	2.82e-05	0.000267	CcSEcCtD
Olopatadine—Clomipramine—CYP2D6—epilepsy syndrome	2.75e-05	0.00827	CrCbGaD
Olopatadine—Vomiting—Topiramate—epilepsy syndrome	2.71e-05	0.000257	CcSEcCtD
Olopatadine—Acepromazine—ALB—epilepsy syndrome	2.71e-05	0.00815	CrCbGaD
Olopatadine—Nortriptyline—CYP2D6—epilepsy syndrome	2.69e-05	0.00809	CrCbGaD
Olopatadine—Rash—Topiramate—epilepsy syndrome	2.68e-05	0.000254	CcSEcCtD
Olopatadine—Dermatitis—Topiramate—epilepsy syndrome	2.68e-05	0.000254	CcSEcCtD
Olopatadine—Imipramine—SLC6A4—epilepsy syndrome	2.67e-05	0.00803	CrCbGaD
Olopatadine—Headache—Topiramate—epilepsy syndrome	2.67e-05	0.000253	CcSEcCtD
Olopatadine—Amitriptyline—SLC6A4—epilepsy syndrome	2.65e-05	0.00798	CrCbGaD
Olopatadine—Doxepin—HTR2A—epilepsy syndrome	2.64e-05	0.00793	CrCbGaD
Olopatadine—Thiothixene—ALB—epilepsy syndrome	2.6e-05	0.00783	CrCbGaD
Olopatadine—Imipramine—CYP2C19—epilepsy syndrome	2.53e-05	0.00762	CrCbGaD
Olopatadine—Nausea—Topiramate—epilepsy syndrome	2.53e-05	0.00024	CcSEcCtD
Olopatadine—Amitriptyline—CYP2C19—epilepsy syndrome	2.51e-05	0.00757	CrCbGaD
Olopatadine—Doxepin—CYP2D6—epilepsy syndrome	2.41e-05	0.00726	CrCbGaD
Olopatadine—Clomipramine—ALB—epilepsy syndrome	2.06e-05	0.00619	CrCbGaD
Olopatadine—Imipramine—HTR2A—epilepsy syndrome	2.05e-05	0.00617	CrCbGaD
Olopatadine—Amitriptyline—HTR2A—epilepsy syndrome	2.04e-05	0.00614	CrCbGaD
Olopatadine—Nortriptyline—ALB—epilepsy syndrome	2.01e-05	0.00605	CrCbGaD
Olopatadine—Clomipramine—ABCB1—epilepsy syndrome	1.96e-05	0.00591	CrCbGaD
Olopatadine—Chlorprothixene—ABCB1—epilepsy syndrome	1.95e-05	0.00588	CrCbGaD
Olopatadine—Imipramine—CYP2D6—epilepsy syndrome	1.88e-05	0.00565	CrCbGaD
Olopatadine—Amitriptyline—CYP2D6—epilepsy syndrome	1.86e-05	0.00561	CrCbGaD
Olopatadine—Doxepin—ABCB1—epilepsy syndrome	1.72e-05	0.00518	CrCbGaD
Olopatadine—Amitriptyline—ALB—epilepsy syndrome	1.39e-05	0.0042	CrCbGaD
Olopatadine—Imipramine—ABCB1—epilepsy syndrome	1.34e-05	0.00403	CrCbGaD
Olopatadine—Amitriptyline—ABCB1—epilepsy syndrome	1.33e-05	0.00401	CrCbGaD
Olopatadine—S100B—Immune System—FGF2—epilepsy syndrome	1.06e-05	0.000189	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GABBR1—epilepsy syndrome	1.06e-05	0.000188	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GRM5—epilepsy syndrome	1.05e-05	0.000187	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CHRM3—epilepsy syndrome	1.05e-05	0.000187	CbGpPWpGaD
Olopatadine—S100A12—Immune System—RELA—epilepsy syndrome	1.04e-05	0.000185	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR10—epilepsy syndrome	1.03e-05	0.000184	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—YWHAZ—epilepsy syndrome	1.03e-05	0.000184	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MTOR—epilepsy syndrome	1.02e-05	0.000182	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NGF—epilepsy syndrome	1.02e-05	0.000182	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HRH3—epilepsy syndrome	1.01e-05	0.000181	CbGpPWpGaD
Olopatadine—S100B—Immune System—BCL2—epilepsy syndrome	1e-05	0.000179	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CX3CR1—epilepsy syndrome	1e-05	0.000179	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—OPRM1—epilepsy syndrome	9.96e-06	0.000178	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCR5—epilepsy syndrome	9.9e-06	0.000177	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CHRM2—epilepsy syndrome	9.85e-06	0.000176	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—BDKRB1—epilepsy syndrome	9.85e-06	0.000176	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CX3CL1—epilepsy syndrome	9.85e-06	0.000176	CbGpPWpGaD
Olopatadine—S100B—Immune System—RELA—epilepsy syndrome	9.82e-06	0.000175	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HTR2A—epilepsy syndrome	9.69e-06	0.000173	CbGpPWpGaD
Olopatadine—S100B—Immune System—MTOR—epilepsy syndrome	9.63e-06	0.000172	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GABBR1—epilepsy syndrome	9.58e-06	0.000171	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR3—epilepsy syndrome	9.41e-06	0.000168	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL1B—epilepsy syndrome	9.39e-06	0.000168	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	9.36e-06	0.000167	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TSC2—epilepsy syndrome	9.2e-06	0.000164	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AGT—epilepsy syndrome	9.19e-06	0.000164	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HRH3—epilepsy syndrome	9.19e-06	0.000164	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—NPY—epilepsy syndrome	9.17e-06	0.000164	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	9.16e-06	0.000163	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CA13—epilepsy syndrome	9.14e-06	0.000163	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCR5—epilepsy syndrome	9.12e-06	0.000163	CbGpPWpGaD
Olopatadine—S100A12—Immune System—JUN—epilepsy syndrome	9.1e-06	0.000162	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—OPRM1—epilepsy syndrome	9.05e-06	0.000161	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GRM2—epilepsy syndrome	9.03e-06	0.000161	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APOE—epilepsy syndrome	9.01e-06	0.000161	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—HTR2A—epilepsy syndrome	8.93e-06	0.000159	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL1B—epilepsy syndrome	8.88e-06	0.000158	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CRH—epilepsy syndrome	8.84e-06	0.000158	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—OXT—epilepsy syndrome	8.84e-06	0.000158	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL2—epilepsy syndrome	8.84e-06	0.000158	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KDR—epilepsy syndrome	8.82e-06	0.000157	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—AKT1—epilepsy syndrome	8.71e-06	0.000155	CbGpPWpGaD
Olopatadine—S100B—Immune System—JUN—epilepsy syndrome	8.61e-06	0.000154	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR3—epilepsy syndrome	8.54e-06	0.000152	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PRKCB—epilepsy syndrome	8.49e-06	0.000152	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—AGT—epilepsy syndrome	8.47e-06	0.000151	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6ST—epilepsy syndrome	8.46e-06	0.000151	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—NPY—epilepsy syndrome	8.32e-06	0.000149	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—AKT1—epilepsy syndrome	8.24e-06	0.000147	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SSTR3—epilepsy syndrome	8.17e-06	0.000146	CbGpPWpGaD
Olopatadine—S100A12—Immune System—SRC—epilepsy syndrome	8.16e-06	0.000146	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—OXT—epilepsy syndrome	8.03e-06	0.000143	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL2—epilepsy syndrome	8.03e-06	0.000143	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL3—epilepsy syndrome	8.03e-06	0.000143	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CRH—epilepsy syndrome	8.03e-06	0.000143	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR2—epilepsy syndrome	8e-06	0.000143	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—SST—epilepsy syndrome	8e-06	0.000143	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ST3GAL3—epilepsy syndrome	7.99e-06	0.000143	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR9—epilepsy syndrome	7.83e-06	0.00014	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR8—epilepsy syndrome	7.83e-06	0.00014	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ARHGEF9—epilepsy syndrome	7.83e-06	0.00014	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NPY2R—epilepsy syndrome	7.83e-06	0.00014	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SSTR1—epilepsy syndrome	7.83e-06	0.00014	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	7.83e-06	0.00014	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—POMC—epilepsy syndrome	7.74e-06	0.000138	CbGpPWpGaD
Olopatadine—S100B—Immune System—SRC—epilepsy syndrome	7.72e-06	0.000138	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GRM3—epilepsy syndrome	7.68e-06	0.000137	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GRM4—epilepsy syndrome	7.68e-06	0.000137	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCL2—epilepsy syndrome	7.57e-06	0.000135	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DUSP4—epilepsy syndrome	7.54e-06	0.000134	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SSTR2—epilepsy syndrome	7.54e-06	0.000134	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL12—epilepsy syndrome	7.52e-06	0.000134	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	7.52e-06	0.000134	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CNR1—epilepsy syndrome	7.38e-06	0.000132	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PLCB1—epilepsy syndrome	7.35e-06	0.000131	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PGF—epilepsy syndrome	7.28e-06	0.00013	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GRM8—epilepsy syndrome	7.28e-06	0.00013	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—SST—epilepsy syndrome	7.26e-06	0.00013	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR2—epilepsy syndrome	7.26e-06	0.00013	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR7—epilepsy syndrome	7.2e-06	0.000128	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—POMC—epilepsy syndrome	7.13e-06	0.000127	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADRA2A—epilepsy syndrome	7.11e-06	0.000127	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCL2—epilepsy syndrome	6.97e-06	0.000124	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GNAO1—epilepsy syndrome	6.95e-06	0.000124	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—OPRD1—epilepsy syndrome	6.95e-06	0.000124	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PDXK—epilepsy syndrome	6.92e-06	0.000124	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	6.92e-06	0.000124	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CERS1—epilepsy syndrome	6.92e-06	0.000124	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ADK—epilepsy syndrome	6.92e-06	0.000124	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	6.92e-06	0.000124	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—FAR1—epilepsy syndrome	6.92e-06	0.000124	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AKT3—epilepsy syndrome	6.86e-06	0.000122	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FGF2—epilepsy syndrome	6.84e-06	0.000122	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL12—epilepsy syndrome	6.83e-06	0.000122	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—BDKRB2—epilepsy syndrome	6.83e-06	0.000122	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CNR1—epilepsy syndrome	6.7e-06	0.00012	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PLCB1—epilepsy syndrome	6.68e-06	0.000119	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR7—epilepsy syndrome	6.66e-06	0.000119	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GRM1—epilepsy syndrome	6.66e-06	0.000119	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CHRM1—epilepsy syndrome	6.66e-06	0.000119	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PDYN—epilepsy syndrome	6.66e-06	0.000119	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR7—epilepsy syndrome	6.54e-06	0.000117	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RELA—epilepsy syndrome	6.35e-06	0.000113	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HBEGF—epilepsy syndrome	6.35e-06	0.000113	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	6.33e-06	0.000113	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GAMT—epilepsy syndrome	6.33e-06	0.000113	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PNPO—epilepsy syndrome	6.33e-06	0.000113	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	6.33e-06	0.000113	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CDC42—epilepsy syndrome	6.26e-06	0.000112	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GFAP—epilepsy syndrome	6.26e-06	0.000112	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GAL—epilepsy syndrome	6.26e-06	0.000112	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AKT3—epilepsy syndrome	6.23e-06	0.000111	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MTOR—epilepsy syndrome	6.23e-06	0.000111	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CASP2—epilepsy syndrome	6.19e-06	0.00011	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CHRM3—epilepsy syndrome	6.19e-06	0.00011	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GRM5—epilepsy syndrome	6.19e-06	0.00011	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AVP—epilepsy syndrome	6.06e-06	0.000108	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CX3CR1—epilepsy syndrome	5.93e-06	0.000106	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—QDPR—epilepsy syndrome	5.89e-06	0.000105	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CA4—epilepsy syndrome	5.89e-06	0.000105	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	5.87e-06	0.000105	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CHRM2—epilepsy syndrome	5.82e-06	0.000104	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—BDKRB1—epilepsy syndrome	5.82e-06	0.000104	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CX3CL1—epilepsy syndrome	5.82e-06	0.000104	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CASP3—epilepsy syndrome	5.73e-06	0.000102	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CDC42—epilepsy syndrome	5.69e-06	0.000101	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GABBR1—epilepsy syndrome	5.66e-06	0.000101	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—JUN—epilepsy syndrome	5.56e-06	9.93e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—COX3—epilepsy syndrome	5.54e-06	9.88e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AVP—epilepsy syndrome	5.5e-06	9.82e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HRH3—epilepsy syndrome	5.43e-06	9.68e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MMP9—epilepsy syndrome	5.41e-06	9.66e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—OPRM1—epilepsy syndrome	5.34e-06	9.53e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.25e-06	9.36e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.25e-06	9.36e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.25e-06	9.36e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	5.25e-06	9.36e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.25e-06	9.36e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	5.15e-06	9.19e-05	CbGpPWpGaD
Olopatadine—S100A12—Immune System—AKT1—epilepsy syndrome	5.07e-06	9.05e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	5.05e-06	9e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	5.04e-06	9e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SRC—epilepsy syndrome	4.99e-06	8.9e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NPY—epilepsy syndrome	4.92e-06	8.77e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	4.92e-06	8.77e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VEGFA—epilepsy syndrome	4.86e-06	8.67e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	4.8e-06	8.56e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	4.8e-06	8.56e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	4.8e-06	8.56e-05	CbGpPWpGaD
Olopatadine—S100B—Immune System—AKT1—epilepsy syndrome	4.8e-06	8.56e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	4.79e-06	8.54e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	4.74e-06	8.46e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CRH—epilepsy syndrome	4.74e-06	8.46e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	4.74e-06	8.46e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—OXT—epilepsy syndrome	4.74e-06	8.46e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	4.74e-06	8.46e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	4.68e-06	8.35e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	4.62e-06	8.24e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	4.58e-06	8.17e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	4.46e-06	7.96e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	4.46e-06	7.96e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.42e-06	7.89e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	4.41e-06	7.87e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	4.41e-06	7.87e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	4.35e-06	7.75e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	4.29e-06	7.65e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SST—epilepsy syndrome	4.29e-06	7.65e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	4.29e-06	7.65e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	4.25e-06	7.59e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	4.2e-06	7.49e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.2e-06	7.48e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	4.18e-06	7.46e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.08e-06	7.28e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	4.03e-06	7.2e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	4.03e-06	7.2e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	4.03e-06	7.19e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	4.02e-06	7.16e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	4e-06	7.13e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.98e-06	7.1e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.98e-06	7.1e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	3.96e-06	7.06e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	3.96e-06	7.06e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	3.95e-06	7.04e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	3.86e-06	6.89e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.79e-06	6.77e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.79e-06	6.77e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	3.75e-06	6.69e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.71e-06	6.62e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	3.68e-06	6.57e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	3.66e-06	6.53e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.64e-06	6.49e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	3.6e-06	6.41e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	3.58e-06	6.39e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.57e-06	6.36e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.5e-06	6.25e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—S100B—epilepsy syndrome	3.4e-06	6.07e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	3.37e-06	6.01e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	3.36e-06	5.99e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.28e-06	5.84e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	3.25e-06	5.8e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.18e-06	5.67e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AKT1—epilepsy syndrome	3.1e-06	5.53e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	3.07e-06	5.49e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	2.99e-06	5.33e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	2.98e-06	5.32e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	2.97e-06	5.31e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.88e-06	5.13e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.88e-06	5.13e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.87e-06	5.13e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	2.84e-06	5.07e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	2.76e-06	4.93e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	2.71e-06	4.83e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	2.57e-06	4.59e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	2.57e-06	4.58e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	2.52e-06	4.49e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	2.46e-06	4.4e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	2.37e-06	4.23e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	2.36e-06	4.21e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.34e-06	4.18e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.28e-06	4.08e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.27e-06	4.05e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	2.16e-06	3.85e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	2.11e-06	3.77e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.05e-06	3.66e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.95e-06	3.48e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.94e-06	3.47e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	1.91e-06	3.41e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.85e-06	3.31e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.83e-06	3.27e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—TH—epilepsy syndrome	1.83e-06	3.26e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	1.77e-06	3.16e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	1.74e-06	3.1e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.61e-06	2.88e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	1.6e-06	2.85e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	1.55e-06	2.77e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.52e-06	2.72e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	1.51e-06	2.7e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.5e-06	2.68e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	1.47e-06	2.62e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.46e-06	2.61e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	1.39e-06	2.49e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.36e-06	2.43e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	1.36e-06	2.42e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.19e-06	2.13e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.17e-06	2.08e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1e-06	1.79e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALB—epilepsy syndrome	9.15e-07	1.63e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	8.66e-07	1.55e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	8.01e-07	1.43e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.02e-07	7.18e-06	CbGpPWpGaD
